Por favor, inténtelo con una nueva búsqueda
Nombre | Edad | Desde | Título |
---|---|---|---|
Steven G. Gourlay | 62 | 2021 | MD, CEO & Director |
Alan Keith Boyd | 66 | - | Member of Scientific Advisory Board |
Geoffrey Edward Duncan Brooke | 65 | 2017 | Independent Non-Executive Chairman |
Christina Kurre Olsen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Christopher Chen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Jeffrey L. Cummings | 73 | 2015 | Member of Xanamem Clinical Advisory Board |
Jonathan Seckl | - | - | Member of Scientific Advisory Board |
Malcolm John McComas | 68 | 2019 | Independent Non-Executive Director |
Brian R. Walker | - | - | Member of Scientific Advisory Board |
Craig W. Ritchie | - | 2015 | Chairman of Xanamem Clinical Advisory Board |
Colin Louis Masters | 76 | 2015 | Member of Xanamem Clinical Advisory Board |
George Morstyn | 73 | 2017 | Independent Non-Executive Director |
Scott Webster | - | - | Member of Scientific Advisory Board |
John Harrison | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Nicki Vasquez | 59 | 2023 | Independent Non-Executive Director |
Dana C. Hilt | 70 | 2022 | Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores